Vancomycin Susceptibility within Methicillin-resistant Staphylococcus aureus Lineages

Howe, RA, Monk, A, Wootton, M, Walsh, TR and Enright, Mark (2004) Vancomycin Susceptibility within Methicillin-resistant Staphylococcus aureus Lineages. Emerging Infectious Diseases, 10 (5). pp. 855-857. ISSN 1080-6040

Preview

Published Version Available under License Creative Commons Attribution. Download (47kB) | Preview

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) with reduced vancomycin susceptibility vancomycin-intermediate S. aureus (VISA) has been reported from many countries. Whether resistance is evolving regularly in different genetic backgrounds or in a single clone with a genetic predisposition, as early results suggest, is unclear. We have studied 101 MRSA with reduced vancomycin susceptibility from nine countries by multilocus sequence typing (MLST), characterization of SCCmec (staphylococcal chromosomal cassette mec), and agr (accessory gene regulator). We found nine genotypes by MLST, with isolates within all five major hospital MRSA lineages. Most isolates (88/101) belonged to two of the earliest MRSA clones that have global prevalence. Our results show that reduced susceptibility to vancomycin has emerged in many successful epidemic lineages with no clear clonal disposition. Increasing antimicrobial resistance in genetically distinct pandemic clones may lead to MRSA infections that will become increasingly difficult to treat.